NEW YORK (GenomeWeb News) – Exact Sciences today priced its common stock offering of 10 million shares at $12.75 per share.

The Madison, Wis.-based molecular diagnostics firm expects net proceeds from the offering to be around $119.7 million. However, the underwriters of the offering have a 30-day option to purchase up to an aggregate of 1,500,000 additional shares of common stock.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.